再生研究:一个干预措施的非随机可行性研究,以减少老患者的抗胆类药物负担
Athagran Nakham1,2, Christine Bond3, Moira Cruickshank4
1Faculty of Pharmaceutical Sciences, Neresuan University, Phitsanulok 65000, Thailand.
通过药剂师的干预,在老年人中降低抗胆固醇负担 (ACB) 是可以在初级保健中实现的. 这种方法可以减少药物副作用并改善生活质量,因此需要进一步研究.
科学领域:
- 老年医学 老年医学
- 药理学 药理学是指药理学的学科.
- 初级保健研究研究初级保健研究
背景情况:
- 抗胆固醇负担 (ACB) 与老年人群的不良健康结果有关.
- 确定有效的干预措施来减少ACB对于老年患者的安全至关重要.
研究的目的:
- 评估药剂师主导干预措施的可行性,以减少老年初级保健患者的ACB.
- 收集数据,为一个更大的,最终的随机对照试验 (RCT) 提供信息.
主要方法:
- 在医学研究委员会框架的指导下进行混合方法可行性研究.
- 干预涉及临床药剂师药物审查和停止处方的建议.
- 数据收集包括患者问卷和患者和医疗保健专业人员的定性访谈.
主要成果:
- 在药剂师主导的咨询和干预中,患者参与度很高.
- 通过成功的招聘和保留率来证明可行性.
- 初步证据表明,药物副作用的减少和改善生活质量的潜力.
结论:
- 药剂师主导的干预措施以减少抗胆激素负担在英国初级保健中是可行的和可以接受的.
- 该干预措施有望改善患者的治疗结果,并需要在RCT中进行进一步的研究.
- 未来的研究应该专注于确认ACB减少策略的有效性和成本效益.
更多相关视频
07:02A Computerized Test Battery to Study Pharmacodynamic Effects on the Central Nervous System of Cholinergic Drugs in Early Phase Drug Development
Published on: February 11, 2019
06:52Assessment of Dependence in Activities of Daily Living Among Older Patients in an Acute Care Unit
Published on: September 30, 2020
相关概念视频
Indirect-Acting Cholinergic Agonists: Pharmacological Actions
At the neuromuscular junction, these agents work by inhibiting the breakdown of acetylcholine, allowing it to remain bound to the receptor and bind to nearby receptors. This process leads to repetitive firing of the endplate, causing muscle...
Cholinergic Antagonists: Therapeutic Uses
Respiratory Tract: Ipratropium, aclidinium, and tiotropium treat asthma, chronic bronchitis, and chronic obstructive pulmonary disease (COPD). They protect against bronchoconstriction caused by irritants like cigarette smoke, sulfur dioxide, and ozone. They also help reduce nasopharyngeal...
Parkinson's Disease: Treatment
Parkinson's Disease is primarily a result of the loss of dopaminergic neurons in the substantia nigra pars compacta. The cornerstone of...
Alzheimer's Disease: Treatment
Cholinergic Antagonists: Pharmacological Actions
Gastrointestinal Effects: Antimuscarinics reduce gut contractions, increase gastric emptying, and slow intestinal transit. They partly inhibit gastric acid secretion...
Direct-Acting Cholinergic Agonists: Therapeutic Uses
